$1.33
-0.02-1.48%
Last update: Oct 1, 4:20 PM
$1.35
N/A
InMed Pharmaceuticals Inc
INMNASDAQ
InMed Pharmaceuticals (INM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | — | — | — |
| Actual | $-1.20 | $-0.69 | $-0.51 | $-0.44 |
| Surprise | — | — | — | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $576339 | $659848 | $820188 | $1.1M |
| Surprise | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | Sep 23, 2022 | $-258.40 | $-5.50 | -4598.2 % |
| Q2 | Feb 14, 2022 | $-155.00 | $-5.75 | -2595.6 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Feb 13, 2024 | $1.24M | $1.39M | -10.8 % |
| Q4 | Sep 23, 2022 | $514.76K | $750.00K | -31.4 % |
| Q2 | Feb 14, 2022 | $265.09K | $120.00K | 120.9 % |
